REporting recommendations for tumor MARKer prognostic studies (REMARK).

REporting recommendations for tumor MARKer prognostic studies (REMARK).

Toon andere (4) versies

Despite years of research and hundreds of reports on tumor markers in oncology, the number of markers that have emerged as clinically useful is pitifully small. Often initially reported studies of a marker show great promise, but subsequent studies on the same or related markers yield inconsistent c...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	McShane, L, Altman, D, Sauerbrei, W, Taube, SE, Gion, M, Clark, G
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2006

Gelijkaardige items

Reporting recommendations for tumor marker prognostic studies (REMARK).
door: McShane, L, et al.
Gepubliceerd in: (2005)

REporting recommendations for tumor MARKer prognostic studies (REMARK).
door: McShane, L, et al.
Gepubliceerd in: (2005)

REporting recommendations for tumor MARKer prognostic studies (REMARK)
door: McShane, L, et al.
Gepubliceerd in: (2005)

REporting recommendations for tumor MARKer prognostic studies (REMARK)
door: McShane, L, et al.
Gepubliceerd in: (2005)

Re: Reporting recommendations for tumor marker prognostic studies (REMARK) - Reply
door: McShane, L, et al.
Gepubliceerd in: (2005)

REporting recommendations for tumour MARKer prognostic studies (REMARK).
door: McShane, L, et al.
Gepubliceerd in: (2005)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.
door: Altman, D, et al.
Gepubliceerd in: (2012)

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.
door: Altman, D, et al.
Gepubliceerd in: (2012)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.
door: Altman, D, et al.
Gepubliceerd in: (2012)

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.
door: Altman, D, et al.
Gepubliceerd in: (2012)

Reporting recommendations for tumor marker prognostic studies.
door: McShane, L, et al.
Gepubliceerd in: (2005)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An abridged explanation and elaboration
door: Sauerbrei, W, et al.
Gepubliceerd in: (2018)

Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
door: Mallett, S, et al.
Gepubliceerd in: (2010)

Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines.
door: Mallett, S, et al.
Gepubliceerd in: (2010)

Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles
door: Sekula, P, et al.
Gepubliceerd in: (2017)

Identification of clinically useful cancer prognostic factors: what are we missing?
door: McShane, L, et al.
Gepubliceerd in: (2005)

[Diagnostic (STARD) and prognostic (REMARK) studies].
door: Altman, D, et al.
Gepubliceerd in: (2005)

Importance of the distinction between quality of methodology and quality of reporting
door: Altman, D, et al.
Gepubliceerd in: (2017)

Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond.
door: Riley, R, et al.
Gepubliceerd in: (2009)

Evidence-based assessment and application of prognostic markers: The long way from single studies to meta-analysis
door: Sauerbrei, W, et al.
Gepubliceerd in: (2006)

Primer: an evidence-based approach to prognostic markers.
door: Altman, D, et al.
Gepubliceerd in: (2005)

CLINICAL PROGNOSTIC MARKERS IN MULTIPLE-SCLEROSIS
door: Paty, D, et al.
Gepubliceerd in: (1979)

Tumor Microenvironment of Metastasis in Human Breast Carcinoma: A Potential Prognostic Marker Linked to Hematogenous Dissemination
door: Gertler, Frank, et al.
Gepubliceerd in: (2014)

hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer.
door: Gee, H, et al.
Gepubliceerd in: (2010)

Tumor markers
door: Hamdon Kashmola, Muhanad Ali
Gepubliceerd in: (2011)

Explicit inclusion of treatment in prognostic modelling was recommended in observational and randomised settings
door: Groenwold, R, et al.
Gepubliceerd in: (2016)

Determination Of Prognostic Markers For Cervical Cancer
door: Ahmad, Rahmatul Wahida
Gepubliceerd in: (2008)

Genetic prognostic markers in colorectal cancer.
door: Houlston, R, et al.
Gepubliceerd in: (1997)

Prognostic value of serum markers for prostate cancer.
door: Stenman, U, et al.
Gepubliceerd in: (2005)

Overinterpretation and misreporting of prognostic factor studies in medical oncology
door: Kempf, E, et al.
Gepubliceerd in: (2016)

Reporting bias in diagnostic and prognostic studies: time for action.
door: Rifai, N, et al.
Gepubliceerd in: (2008)

Prognostic Markers Of Resistance And Relapse In Acute Leukaemia
door: Pon, Maha Abdullah@Maha-Lakswmi
Gepubliceerd in: (2003)

Genetic prognostic and predictive markers in colorectal cancer.
door: Walther, A, et al.
Gepubliceerd in: (2009)

Rational identification of prognostic markers of breast cancer
door: Ibrahim, M, et al.
Gepubliceerd in: (2014)

Reporting performance of prognostic models in cancer: a review.
door: Mallett, S, et al.
Gepubliceerd in: (2010)

Less utilized prognostic markers in acute myeloid leukaemia
door: Abdullah, Maha
Gepubliceerd in: (2016)

Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.
door: Calvert, N, et al.
Gepubliceerd in: (2003)

P27 is a molecular tumor marker prognostic for survival in 118 NSCLC patients (PTS) treated with radiation chemotherapy on ECOG3590
door: Martin, N, et al.
Gepubliceerd in: (2006)

A prognostic model for ovarian cancer.
door: Clark, T, et al.
Gepubliceerd in: (2001)

Prognosis and prognostic research: Developing a prognostic model
door: Royston, P, et al.
Gepubliceerd in: (2009)